CME CME Group Inc.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. CME Group Inc. partners with FutureSports to futures on sports indexes. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.…
Industry Peers
Financial Data & Stock ExchangesKey Statistics
About CME Group (NASDAQ: CME)
›
CME Group (NASDAQ: CME) is listed on Nasdaq, where its shares trade in USD. It belongs to the Financial Data & Stock Exchanges industry, part of the Financial Services sector, and reports about 3,875 employees.
The shares were at 306.31 USD on 19 November 2026, up 16.1% over 52 weeks. Its 52-week range is 218.33 USD to 329.16 USD: the price is 6.9% below the high and 40.3% above the low.
At a market capitalisation of 109.64B USD, it trades at 25.1 times trailing earnings and 23.1 times forward earnings. The median trailing P/E of its 19 largest Financial Data & Stock Exchanges peers is 23.3, so CME is valued in line with them. It pays a dividend yielding 1.68% (it pays out 93% of its earnings), against a median of 1.29% among the dividend payers in that peer group.
CME Group reports return on equity of 14.2%, an operating margin of 66.2% and revenue up 13.0% year over year.
Its debt exceeds its cash by 1.52B USD, a debt-to-equity ratio of 0.12. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 16 analysts cover the stock, with an average rating of Buy; their mean price target of 318.13 USD is 3.9% above the current price. The next earnings report is expected on 3 February 2027.